The deal size was increased to 9.6M shares of common stock from 6.7M shares of common stock. Lake Street acted as sole book running manager for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AYTU:
- Aytu BioPharma enters exclusive agreement with Fabre-Kramer Pharmaceuticals
- Aytu BioPharma prices 9.6M shares at $1.50 in upsized public offering
- Aytu BioPharma announces exclusive commercialization agreement for Exxua
- Aytu BioPharma files to sell 6.74M shares of common stock
- Aytu BioScience Holds 2025 Annual Meeting
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue